In this current research, we explored whether magnoflorine could exert its anti-inflammatory action on LPS-induced ALI in mice and in RAW264.7 cells by inhibiting the NF-κB and MAPK signaling pathways. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.